Low-dose mTOR inhibition by rapamycin attenuates progression in anti-thy1-induced chronic glomerulosclerosis of the rat.
Krämer S, Wang-Rosenke Y, Scholl V, Binder E, Loof T, Khadzhynov D, Kawachi H, Shimizu F, Diekmann F, Budde K, Neumayer HH, Peters H.
Krämer S, et al. Among authors: kawachi h.
Am J Physiol Renal Physiol. 2008 Feb;294(2):F440-9. doi: 10.1152/ajprenal.00379.2007. Epub 2007 Dec 19.
Am J Physiol Renal Physiol. 2008.
PMID: 18094032
Free article.